Elekta AB (EKTAY)
6.935
+0.20
(+3.05%)
USD |
OTCM |
Apr 22, 16:00
Elekta Gross Profit Margin (Quarterly): 36.68% for Jan. 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 36.68% |
October 31, 2023 | 35.82% |
July 31, 2023 | 41.51% |
April 30, 2023 | 37.67% |
January 31, 2023 | 38.09% |
October 31, 2022 | 36.24% |
July 31, 2022 | 38.71% |
April 30, 2022 | 37.04% |
January 31, 2022 | 36.73% |
October 31, 2021 | 38.60% |
July 31, 2021 | 37.06% |
April 30, 2021 | 38.48% |
January 31, 2021 | 38.73% |
October 31, 2020 | 40.89% |
July 31, 2020 | 45.86% |
April 30, 2020 | 42.61% |
January 31, 2020 | 41.99% |
October 31, 2019 | 40.98% |
July 31, 2019 | 42.60% |
April 30, 2019 | 45.19% |
January 31, 2019 | 40.75% |
October 31, 2018 | 41.35% |
July 31, 2018 | 39.13% |
April 30, 2018 | 42.24% |
January 31, 2018 | 43.40% |
Date | Value |
---|---|
October 31, 2017 | 43.37% |
July 31, 2017 | 46.41% |
April 30, 2017 | 42.42% |
January 31, 2017 | 39.73% |
October 31, 2016 | 42.11% |
July 31, 2016 | 40.60% |
April 30, 2016 | 42.69% |
January 31, 2016 | 39.54% |
October 31, 2015 | 41.76% |
July 31, 2015 | 39.53% |
April 30, 2015 | 41.61% |
January 31, 2015 | 39.11% |
October 31, 2014 | 41.72% |
July 31, 2014 | 33.94% |
April 30, 2014 | 46.51% |
January 31, 2014 | 39.41% |
October 31, 2013 | 43.47% |
July 31, 2013 | 42.15% |
April 30, 2013 | 48.19% |
January 31, 2013 | 44.77% |
October 31, 2012 | 46.36% |
July 31, 2012 | 43.95% |
April 30, 2012 | 48.67% |
January 31, 2012 | 48.38% |
October 31, 2011 | 43.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
35.82%
Minimum
Oct 2023
45.86%
Maximum
Jul 2020
39.57%
Average
38.66%
Median
Gross Profit Margin (Quarterly) Benchmarks
Abliva AB | -- |
Karolinska Development AB | -- |
Calliditas Therapeutics AB | 95.06% |
Oncopeptides AB | -- |
Olink Holding AB | 71.00% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 14.25% |
Return on Assets | 4.75% |
Return on Invested Capital | 9.17% |
Profit Margin (Quarterly) | 6.72% |
Operating Margin (Quarterly) | 12.52% |
Return on Net Operating Assets | 5.37% |